0001853921 2026-07-23 2026-07-23 0001853921 1 2026-07-23 2026-07-23 iso4217:USD pure S-1 S-1MEF EX-FILING FEES 333-297246 0001853921 Scribe Therapeutics, Inc. N/A N/A S-1 Scribe Therapeutics, Inc. false Equity Common stock, par value $0.001 per share true 24667500.00 0.0001381 3406.58 24667500.00 3406.58 0.00 0.00 3406.58 (1) Represents only the additional $24,667,500 of shares of common stock being registered pursuant to this registration statement and includes shares of common stock that the underwriters have the option to purchase. Does not include the $123,337,500 of shares of common stock that were previously registered on the Registration Statement on Form S-1 (File No. 333-297246), as amended (the "Prior Registration Statement"). (2) Based on the public offering price. (3) The registration fee is calculated in accordance with Rule 457(o) under the Securities Act of 1933, as amended (the "Securities Act"), based on the maximum aggregate offering price. The registrant previously registered an aggregate of $123,337,500 of shares of its common stock on the Prior Registration Statement, which was declared effective by the Securities and Exchange Commission on July 23, 2026. In accordance with Rule 462(b) under the Securities Act, an additional amount of securities having a maximum aggregate offering price of $24,667,500 is hereby registered, which includes shares of common stock that the underwriters have the option to purchase.